Taxotere Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients
Condition:   Breast Cancer Interventions:   Drug: Dalcelli、Exemestane、Gosserine;   Drug: Docetaxel for injection、Epirubicin hydrochloride for injection、Cyclophosphamide for injection Sponsor:   Tianjin Medical University Cancer Institute and Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2023 Category: Research Source Type: clinical trials